Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MEN10207 is a peptide neurokinin-2 (NK2) receptor antagonist.1 It inhibits contractions induced by neurokinin A (NKA) in endothelium-deprived isolated rabbit pulmonary artery (pA2 = 7.89), which is endogenously enriched in NK2 receptors. It is selective for NK2 receptors in isolated rabbit pulmonary artery over NK2 receptors in isolated hamster trachea (pA2 = 5.9 using NKA as an agonist) and NK1 receptors in isolated guinea pig ileum (pA2 = 5.52 using substance P methyl ester as an agonist), tissues that highly express these respective receptors, as well as NK3 receptors in isolated guinea pig cerebral cortex membranes (Ki = >10 μM). In vivo, MEN10207 (1 μmol/kg) inhibits increases in bladder motility induced by the NK2 receptor agonist [β-Ala8]-NKA (4-10) in anesthetized rats, as well as [β-Ala8]-NKA (4-10)-induced increases in bronchoconstriction in anesthetized guinea pigs. However, MEN10207 also induces bladder motility in anesthetized rats and bronchoconstriction in anesthetized guinea pigs when administered alone.
WARNING This product is not for human or veterinary use.
1. In vivo evidence for tachykininergic transmission using a new NK-